AI Verdict
REGN has stronger fundamentals based on our AI analysis.
REGN vs TMO Fundamental Comparison
| Metric | REGN | TMO |
|---|---|---|
| Revenue | $14.3B | $44.6B |
| Net Income | $4.5B | $6.7B |
| Net Margin | 31.4% | 15.0% |
| ROE | 14.4% | 12.6% |
| ROA | 11.1% | 6.1% |
| Current Ratio | 4.13x | 1.89x |
| Debt/Equity | 0.06x | 0.73x |
| EPS | $41.48 | $17.74 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
REGN vs TMO: Frequently Asked Questions
Is REGN or TMO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. REGN is rated BUY (80% confidence) while TMO is rated BUY (73% confidence). This is not investment advice.
How does REGN compare to TMO fundamentally?
REGENERON PHARMACEUTICALS, INC. has ROE of 14.4% vs THERMO FISHER SCIENTIFIC INC.'s 12.6%. Net margins are 31.4% vs 15.0% respectively.
Which stock pays higher dividends, REGN or TMO?
REGN has a dividend yield of N/A or no dividend while TMO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in REGN or TMO for long term?
For long-term investing, consider that REGN has BUY rating with 80% confidence, while TMO has BUY rating with 73% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about REGN vs TMO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REGN vs TMO, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.